Chondroitin sulfate - Robapharm

Drug Profile

Chondroitin sulfate - Robapharm

Alternative Names: Structum

Latest Information Update: 07 Mar 2001

Price : $50

At a glance

  • Originator Robapharm
  • Class Anti-inflammatories; Antirheumatics; Glycosaminoglycans
  • Mechanism of Action Collagen stimulants; Leucocyte elastase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Osteoarthritis

Most Recent Events

  • 07 Mar 2001 A study in patients with osteoarthritis has been added to the therapeutic trials section
  • 21 Jan 1999 Launched for Osteoarthritis in France (PO)
  • 21 Jan 1999 Launched for Osteoarthritis in Switzerland (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top